Attitude towards and factors affecting uptake of population‐basedBRCAtesting in the Ashkenazi Jewish population: a cohort study
Authors:
- 15 February 2019
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 126 (6) , 784-794
Abstract
Objective: To evaluate factors affecting unselected population‐basedBRCAtesting in Ashkenazi Jews (AJ).Design: Cohort‐study set within recruitment to the GCaPPS trial (ISRCTN73338115).Setting: North London AJ population.Population or sample: Ashkenazi Jews women/men >18 years, recruited through self‐referral.Methods: Ashkenazi Jews women/men underwent pre‐test counselling forBRCAtesting through recruitment clinics (clusters). Consenting individuals provided blood samples forBRCAtesting. Data were collected on socio‐demographic/family history/knowledge/psychological well‐being along with benefits/risks/cultural influences (18‐item questionnaire measuring ‘attitude’). Four‐item Likert‐scales analysed initial ‘interest’ and ‘intention‐to‐test’ pre‐counselling. Uni‐ and multivariable logistic regression models evaluated factors affecting uptake/interest/intention to undergoBRCAtesting. Statistical inference was based on cluster robust standard errors and joint Wald tests for significance. Item‐Response Theory and graded‐response models modelled responses to 18‐item questionnaire.Main outcome measures: Interest, intention, uptake, attitude towardsBRCAtesting.Results: A total of 935 individuals (women = 67%/men = 33%; mean age = 53.8 (SD = 15.02) years) underwent pre‐test genetic‐counselling. During the pre‐counselling, 96% expressed interest in and 60% indicated a clear intention to undergoBRCAtesting. Subsequently, 88% opted forBRCAtesting.BRCA‐related knowledge (P = 0.013) and degree‐level education (P = 0.01) were positively and negatively (respectively) associated with intention‐to‐test. Being married/cohabiting had four‐fold higher odds forBRCAtesting uptake (P = 0.009). Perceived benefits were associated with higher pre‐counselling odds for interest in and intention to undergoBRCAtesting. Reduced uncertainty/reassurance were the most important factors contributing to decision‐making. Increased importance/concern towards risks/limitations (confidentiality/insurance/emotional impact/inability to prevent cancer/marriage ability/ethnic focus/stigmatisation) were significantly associated with lower odds of uptake ofBRCAtesting, and discriminated between acceptors and decliners. Male gender/degree‐level education (P = 0.001) had weaker correlations, whereas having children showed stronger (P = 0.005) associations with attitudes towardsBRCAtesting.Conclusions: BRCAtesting in theAJpopulation has high acceptability. Pre‐test counselling increases awareness of disadvantages/limitations ofBRCAtesting, influencing final cost‐benefit perception and decision‐making on undergoing testing.Tweetable BRCAtesting in Ashkenazi Jews has high acceptability and uptake. Pre‐test counselling facilitates informed decision‐making.Keywords
Funding Information
- Queen Mary University of London (C16420/A18066)
This publication has 36 references indexed in Scilit:
- Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referralGenetics in Medicine, 2017
- Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experienceGenetics in Medicine, 2017
- Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutationsJournal of Medical Genetics, 2016
- Genetic Screening for Gynecological Cancer: Where are We Heading?Future Oncology, 2015
- Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based TestingJNCI: Journal of the National Cancer Institute, 2014
- Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled TrialJNCI: Journal of the National Cancer Institute, 2014
- Precision Medicine Meets Public Health: Population Screening for BRCA1 and BRCA2JNCI: Journal of the National Cancer Institute, 2014
- Population-based screening for breast and ovarian cancer risk due toBRCA1andBRCA2Proceedings of the National Academy of Sciences, 2014
- Patient satisfaction and cancer‐related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2Clinical Genetics, 2010
- Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish WomenJournal of Clinical Oncology, 2010